News & Partnering

Press releases

Year

November 10, 2022

Imvax Presents Preclinical Data at SITC 2022 Supporting Mechanism of Action and Anti-tumor Activity of its Immunotherapy Platform Across Multiple Tumor Types

October 6, 2022

Imvax to Present New Data on Tumor-Derived Immunotherapy Platform at 2022 SITC Meeting

September 29, 2022

Imvax Presents New Data on Personalized Whole-Tumor Derived Immunotherapeutic Platform at 2022 International Cancer Immunotherapy Conference

September 22, 2022

Imvax to Present New Data on Tumor-Derived Immunotherapy Platform at 2022 International Cancer Immunotherapy Conference

In the News

Year

August 11, 2022 | Philadelphia Business Journal

Imvax Named as a PHL Inno Inaugural Fire Awards Honoree

July 5, 2022 | Philadelphia Business Journal,

Life sciences startup leaders talk about challenges of growing in Philadelphia

Upcoming Events

None at this time, stay tuned!